FIGS stock has posted strong multi year gains, yet the latest valuation checks suggest the shares now look expensive rather than like a clear bargain. After such a sharp move, investors are weighing recent momentum against signals that point to a rich market multiple.
- Over the past 3 years, FIGS has returned 147.9%, which sets a high bar for what needs to go right from here to justify the move.
- The company’s ability to grow its healthcare apparel franchise and protect margins can support the current share price, while any pressure on profitability or slower than expected growth may challenge today’s valuation.
- With a value score of 1 out of 6, FIGS does not screen as a clear bargain on the broader valuation checks.
The issue now is whether FIGS’ recent share price strength leaves enough upside to compensate for the relatively full looking valuation.
Contrast FIGS’ recent performance with a curated list of stocks that pair quality fundamentals with more moderate pricing signals through our 44 high quality undervalued stocks.
Has FIGS Run Too Far on Earnings?
P/E is a useful yardstick for FIGS because the stock is being priced squarely on its earnings power. FIGS currently trades on a P/E of 41.4x, which is roughly double the peer average of 21.0x and also well above the broader luxury industry average of 16.7x. That places FIGS on a clear premium to many companies with similar business models and sector exposure.
The fair P/E ratio for FIGS, based on its profile and risk characteristics, is estimated at 17.3x. Compared with the current 41.4x multiple, the stock trades at a large premium to this tailored benchmark. This indicates that many positive expectations may already be reflected in the price, which could leave less room for disappointment around earnings.
On the P/E multiple, FIGS stock appears overvalued relative to both its fair ratio and sector peers.
See what the numbers say about this price — find out in our valuation breakdown.
The FIGS Narrative: What Would Justify Today's Price?
Simply Wall St Narratives pick up where the FIGS valuation puzzle leaves off and explain which paths for growth, margins and earnings would need to occur for the stock to be worth materially more or less than it is today. Each narrative ties a fair value estimate to a specific potential storyline about FIGS' catalysts and risks, so you can track over time which version of events appears to be unfolding on the Community page.
FIGS investors are split between a scenario that leans on international growth and margin strength and a more cautious view that highlights execution risk and brand dependence.
Bull case: 17% undervalued
"Strategic international expansion, with recent launches in Japan, South Korea, and twelve new Latin American markets, is poised to diversify revenues and accelerate top-line growth beyond the U.S. core over the next several years..."
Read the full Bull Case to see why FIGS could be undervalued
Bear case: 7% overvalued
"Execution. FIGS is in a precarious position where it has experienced a monumental decline in share price following a weakness in performance (margin decline post-pandemic and a slowdown in growth now)..."
Read the full Bear Case to see why FIGS could be overvalued
Do you think there's more to the story for FIGS? Head over to our Community to see what others are saying!
The Bottom Line
FIGS looks overvalued on current market multiples, which means expectations for earnings and margins are already set quite high. The low value score reinforces that broader valuation checks are not especially supportive at today’s price. From here the key question is whether FIGS can deliver the growth and margin resilience that bullish investors expect, or whether any stumble in execution or brand traction leads the market to reassess the premium multiple.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com